These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
518 related articles for article (PubMed ID: 33331874)
1. Using Historical Data to Support Approval of Drug Products for Ophthalmia Neonatorum: Innovative Approach Toward Evidence-Based Medicine. Sun H; Temeck JW; McCune SK; Chambers WA JAMA Ophthalmol; 2021 Feb; 139(2):214-217. PubMed ID: 33331874 [TBL] [Abstract][Full Text] [Related]
2. [Treatment of conjunctivitis]. Barabási Z Orv Hetil; 2004 Oct; 145(41):2107-10. PubMed ID: 15586586 [No Abstract] [Full Text] [Related]
3. Neonatal ocular prophylaxis in the United States: is it still necessary? Franco S; Hammerschlag MR Expert Rev Anti Infect Ther; 2023 May; 21(5):503-511. PubMed ID: 36691840 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of topical ophthalmic prophylaxis in prevention of ophthalmia neonatorum. Matinzadeh ZK; Beiragdar F; Kavemanesh Z; Abolgasemi H; Amirsalari S Trop Doct; 2007 Jan; 37(1):47-9. PubMed ID: 17326893 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials. Comstock TL; Paterno MR; Usner DW; Pichichero ME Paediatr Drugs; 2010 Apr; 12(2):105-12. PubMed ID: 20218747 [TBL] [Abstract][Full Text] [Related]
12. Can we use azithromycin eye drops for gonococcal ophthalmia prophylaxis in the United States? Franco S; Hammerschlag MR Expert Rev Anti Infect Ther; 2024 Jun; 22(6):373-377. PubMed ID: 38781483 [TBL] [Abstract][Full Text] [Related]
13. The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis. Benitez-Del-Castillo J; Verboven Y; Stroman D; Kodjikian L Clin Drug Investig; 2011; 31(8):543-557. PubMed ID: 21604820 [TBL] [Abstract][Full Text] [Related]
14. Besifloxacin: a topical fluoroquinolone for the treatment of bacterial conjunctivitis. Chang MH; Fung HB Clin Ther; 2010 Mar; 32(3):454-71. PubMed ID: 20399984 [TBL] [Abstract][Full Text] [Related]
15. A comparison of silver nitrate with erythromycin for prophylaxis against ophthalmia neonatorum. Zanoni D; Isenberg SJ; Apt L Clin Pediatr (Phila); 1992 May; 31(5):295-8. PubMed ID: 1582096 [TBL] [Abstract][Full Text] [Related]
16. Safety and tolerability of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis: data from six clinical and phase I safety studies. Comstock TL; Paterno MR; Decory HH; Usner DW Clin Drug Investig; 2010; 30(10):675-85. PubMed ID: 20629472 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children. Silverstein BE; Allaire C; Bateman KM; Gearinger LS; Morris TW; Comstock TL Clin Ther; 2011 Jan; 33(1):13-26. PubMed ID: 21397770 [TBL] [Abstract][Full Text] [Related]
18. Morganella as a cause of ophthalmia neonatorum. Ward MF; Olson DJ; Taggart M; Grace SF J AAPOS; 2018 Feb; 22(1):81-82. PubMed ID: 29288840 [TBL] [Abstract][Full Text] [Related]
19. Ophthalmia neonatorum with special reference to Chlamydia trachomatis. Diagnosis and treatment. Sandström I Acta Paediatr Scand Suppl; 1986; 330():1-27. PubMed ID: 3107338 [No Abstract] [Full Text] [Related]
20. Conjunctivitis of the newborn. de Toledo AR; Chandler JW Infect Dis Clin North Am; 1992 Dec; 6(4):807-13. PubMed ID: 1460264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]